Microgynon ED Combination* Tablet POM, R x84

Sugar-coated tablets - each active tablet contains Levonorgestrel 150 micrograms and Ethinylestradiol 30 micrograms

Therapeutic indications:
• Oral contraception and the recognised gynaecological indications for such oestrogen-progestogen combinations.
• The decision to prescribe Microgynon 30 ED should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Microgynon 30 ED compares with other combined hormonal contraceptives (CHCs)

Features

Nature and contents of container:
• Deep drawn strips made of polyvinyl chloride film with counter-sealing foil made of aluminium with heat sealable coating.
• Presentation: Each carton contains either 1 or 3 blister memo-packs. Each blister memo-pack contains 21 active tablets and 7 placebo tablets.

Special precautions for storage:
• Not applicable.